Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-12 Sale |
2024-09-16 8:50 pm |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
88,657 | $4.3022 | $381,423 | 808,921 (Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 4:15 pm |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
132,985 | $3.4853 | $463,487 | 709,518 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-25 Option Award |
2025-01-28 4:05 pm |
N/A 2035-01-25 |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
825,000 | $0 | 825,000 (Direct) |
View |
| 2024-11-29 Option Award |
2024-12-03 5:10 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | Scots-Knight Denise Director |
18,169 | $0 | 78,400 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 4:49 pm |
2024-09-11 2025-01-25 |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
188,060 | $0 | 897,578 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 6:15 pm |
2024-06-21 2025-01-25 |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
282,090 | $0 | 1,030,563 (Direct) |
View |
| 2024-01-25 Option Award |
2024-01-26 4:15 pm |
N/A 2034-01-25 |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
850,000 | $0 | 850,000 (Direct) |
View |
Ownership |
2024-01-02 4:15 pm |
N/A N/A |
Mereo Biopharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
0 | $0 | 4,459,512 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-04 5:32 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | Scots-Knight Denise Director |
20,374 | $0 | 60,231 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 5:07 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | Scots-Knight Denise Director |
18,649 | $0 | 39,857 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 5:08 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | Scots-Knight Denise Director |
7,307 | $0 | 21,208 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 6:29 pm |
N/A N/A |
Elanco Animal Health Inc | ELAN | Scots-Knight Denise Director |
5,885 | $0 | 13,901 (Direct) |
View |